1. Among participants with non-alcoholic fatty liver disease, greater consumption of dietary niacin was associated with a reduction in the ...
1. The risk of cardiovascular disease (CVD) and all-cause death for individuals with type 2 diabetes mellitus (T2DM) is increased ...
1. In this randomized controlled trial, among patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis, resmetirom was superior to placebo ...
1. Patients randomized to have Zinc (Zn) supplementation incorporated into an 8-week diet and exercise intervention for patients with NAFLD ...
1. This analysis of a population-based cohort found that those who engaged in high and moderate decreasing amounts of vigorous ...
Noninvasive Bioelectronic Treatment of Postcesarean Pain: A Randomized Trial 1. In this randomized, sham-controlled clinical trial, the use of Transcutaneous ...
1. Patients in the camrelizumab-rivoceranib group reported significantly greater progression-free survival than the sorafenib group. 2. Treatment-related deaths were comparable ...
1. In this case-control study, younger age of onset of non-alcoholic fatty liver disease (NAFLD) was associated with greater cancer ...
1. In this pilot program conducted in Ethiopia, researchers demonstrated the long-term benefits and feasibility of treatment for chronic hepatitis ...
Exposure to Neighborhood Walkability and Residential Greenness and Incident Fracture 1. In this longitudinal cohort study, neighborhood walkability and greenness ...
